Cancer therapy using bone-seeking isotopes

Physics in Medicine and Biology

Volumn 41, Issue 10, 1996, Pages 2027-2042

  Lewington, V J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID RE 186; LEXIDRONAM SAMARIUM SM 153; PENTETATE INDIUM IN 113M; PHOSPHORUS 32; RADIOISOTOPE; STRONTIUM 89;

ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER THERAPY; EARLY RESPONSE GENE; MICRODOSIMETRY; PRIORITY JOURNAL; RADIOBIOLOGY;

BONE NEOPLASMS; HUMANS; NEOPLASMS; PALLIATIVE CARE; PHOSPHORUS RADIOISOTOPES; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RHENIUM; SAMARIUM; STRONTIUM; TIN RADIOISOTOPES;

EID: 0029763967     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/41/10/012     Document Type: Article

References (78)

1. Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkila J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainien E and Kulmala J 1994 Samarium-153 EDTMP in bone metastases J. Nucl. Bio.l Med. 34 (suppl 1) 123-7
2. Aitasalo K 1986 Effect of variation and early enzymatic changes in healing of mandibular perisoteum and bone Acta Radiol. Oncol. 25 207-12
3. Ariel I M and Hassouna H 1985 Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus Int. Surgery 70 63-6
4. Atkins H L et al 1993 Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful metastases Radiology 186 279-83
5. 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation Am. J. Clin. Oncol. 9 264-8
6. Bates T 1989 Radiotherapy for bone metastases Clin. Oncol. 1 57-8
7. Beddoe A H 1978 A quantitative study of the structure of trabecular bone in man, rhesus monkey, beagle and miniature pig Calcif. Tiss. Res. 25 273-81
8. Blake G M, Zivanovic M A, McEwan A J and Ackery D M 1986 Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate Eur. J. Nucl. Med. 12 447-54
9. Blake G M, Zivanovic M A, McEwan A J, Condon B R and Ackery D M 1987 Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma Br. J. Radiol. 60 253-9
10. Blake G M, Zivanovic M A, Blacquiere R M, Fine D R, McEwan A J and Ackery D M 1988 Strontium-89 therapy: measurement of absorbed dose to skeletal metastases J. Nucl. Med. 29 549-57
11. Blanchard J M 1992 Protooncogene c-fos - a molecular go between Med. Sci. 8 455-70
12. Boyce B F 1991 Normal bone remodelling and its disruption in metastatic bone disease Bone Metastases: Diagnosis and Treatment ed R Rubens and I Fogelman (London: Springer) pp 11-30
13. Breen S L, Powe J E and Porter A T 1992 Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma J. Nucl. Med. 33 1316-23
14. Burnet N G, Williams C and Howard N 1990 Phosphorus 32 for intractable bony pain from carcinoma of the prostate Clin. Oncol. 2 220-3
15. Cheung A and Driedger A A 1980 Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate Radiology 134 209-12
16. Cole D J 1989 A randomised trial of single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases Clin. Oncol. 1 59-62
17. Collins C, Eary J F, Donaldson G, Vernon C, Bush N E, Petersdorf S, Livingstone R B, Gordon E E, Chapman R and Applebaum F R 1993 Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: A phase I/II trial J. Nucl. Med. 34 1839-44
18. Dearnaley D P, Bayly R J, A'Hearn R P, Gadd J, Zivanovic M A and Lewington V J 1992 Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Clin. Oncol. 4 101-7
19. de Klerk J M H, van Dijk A, van het Schip A D, Zonnenberg B A and van Rijk P P 1992a Pharmacokinetics of Re-186 after administration of Re-186-HEDP to patients with bone metastases J. Nucl. Med. 33 646-51
20. de Klerk J M H, van Dijk A, van Rijk P P, Zonnenberg B A and van het Schip A D 1991 Pharmacokinetics of rhenium 186 after administration of rhenium 186 HEDP in patients with metastatic bone cancer J. Nucl. Med. 32 1082
21. de Klerk J M H, van het Schip A D, Zonnenberg B A, van Dijk A, Blijhan GH and van Rijk P P 1994b Phase I study of Re-186-HEDP in patients with bone metastases originating from breast cancer Re-186-HEDP in Treatment of Metastatic Bone Disease: Pharmacokinetics and Toxicity de Klerk J M H Thesis Universiteit Utrecht, Faculteit Geneeskunde pp 81-95
22. de Klerk J M H, Zonnenberg B A, Quirjingen J M S P, van net Schip A D, van Dijk A and van Rijk P P 1992b Re-186-HEDP: Palliation of Painful Bone Metastases (Petten: Mallinckrodt Medical BV)
23. de Klerk J M H, Zonnenberg B A, van het Schip A D, van Dijk A, Han S H, Quirijnen J M S P, Blijham G H and van Rijk P P 1994a Dose escalation study of Re-186-HEDP in patients with metastatic prostate cancer Eur. J. Nucl. Med. 21 1113-20
24. Dodwell D J 1992 Malignant bone resorption: cellular and biochemical mechanisms Ann. Oncol. 3 257-67
25. Eary J F, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, Hannen S, Ferency S, Addison S, Applebaum F and Gordon E E 1993 Samarium-153-EDTMP biodistribution and dosimetry. J. Nucl. Med. 34 1031-6
26. Englaro E E, Schroder L E, Thomas S R, Williams C G and Maxon H R III 1992 Safety and efficacy of repeated sequential administrations of Re-186(Sn)-HEDP as palliative therapy for painful skeletal metastases. Initial case reports of two patients Clin. Nucl. Med. 17 41-4
27. Farhangi M, Holmes R, Vorhut Q, Logan K and Singh A 1992 Samarium-153 EDTMP: pharmacokinetics, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer J. Nucl. Med. 33 1451-8
28. Friedell H L and Storaasli J P 1950 The use of radioactive phosphorus in the treatment of carcinoma of the breast with widespread metastases to bone Am. J. Roentgenol. Radiat. Ther. 64 559-75
29. Goeckeler W F, Edwards B, Volkert W A, Holmes R A, Simon J and Wilson D 1987 Skeletal localisation of samarium-153 chelates: potential therapeutic bone agents J. Nucl. Med. 28 495-504
30. Heggie J C P 1991 Radiation absorbed dose calculations for Samarium 153 EDTMP localized in bone J. Nucl. Med. 32 840-4
31. Hellman S and Weichselbaum R R 1994 Radiation oncology J. Am. Med. Ass. 271 1712-4
32. Hertz S 1950 Modifying effect of steroid hormone therapy on human neoplastic tissue as judged by radioactive phosphorus (P32) J. Clin. Invest. 29 821
33. Hoskin P J 1991 Radiotherapy in the management of bone metastases Bone Metastases: Diagnosis and Treatment ed R D Rubens and I Fogelman (London: Springer) pp 171-85
34. Hoskin P J, Ford H T and Harmer C L 1989 Hemibody irradiation for metastatic bone pain in two histologically distinct groups of patients. Clin. Oncol. 1 67-9
35. Hoskin P J, Price P, Easton D, Regan J, Austin D, Palmer S, Yarnold J R 1992 A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain Radiother. Oncol. 23 74-8
36. International Commission for Radiological Protection 1979 Metabolic data for strontium: limits for intakes of radionuclides by workers. ICRP Publication 30 part 1 (Oxford: Pergamon) pp 77-8
37. Kharbanda S, Yuan Z M, Rubn E, Weichselbaum R R and Kufe D 1994 Activation of SRC-like P56/P53(lyn) tyrosine kinase by ionizing radiation J. Biol. Chem. 269 20 739-43
38. Laing A H, Ackery D M, Bayly R J, Ruchanan R B, Lewington V J, McEwan A J, Macleod P M and Zivanovic M A 1991 Strontium-89 therapy for pain palliation in prostatic skeletal malignancy Br. J. Radiol. 64 816-22
39. Lewington V J, McEwan A J, Ackery D M, Bayly R J, Keeling D H, Macleod P M, Porter A and Zivanovic M A 1991 A prospective randomised double blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostatic cancer metastatic to bone Eur. J. Cancer 27 954-58
40. Logan K W, Volkert W A and Holmes R A 1987 Radiation dose calculations in persons receiving injection of Sm-153 EDTMP J. Nucl. Med. 28 505-9
41. Manome Y, Datta R and Fine H A 1993a Early response gene induction following DNA damage in astrocytoma cell lines Biochem. Pharmacol. 45 1677-84
42. Manome Y, Datta R, Tanija N, Shafman T, Bump E, Mass R, Weichslbaum R and Kufe D 1993 Coinduction of c jun gene expression and internuceosomal DNA fragmentation by ionizing radiation Biochemistry 32 10607-13
43. Maxfield J R Jr, Maxfield J G S and Maxfield W S 1958 The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate Southern Med. J. 51 320-7
44. Maxon H R III, Deutsch E A, Thomas S R, Libson K, Lukes S J, Williams C C and Ali S 1988 Re-186(Sn)-HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies Radiology 166 501-7
45. Maxon H R III et al 1990 Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone resistant prostate cancer Radiology 176 155-9
46. Maxon H R III et al 1991 Rhenium-186(Sn)-HEDP for treatment of painful osseous metastases: results of a double blind crossover comparison with placebo J. Nucl. Med. 32 1877-81
47. Mays C W 1973 Cancer induction in man from internal radioactivity Health Phys. 25 585-92
48. McCabe L R, Kockx M, Lian J and Stein J 1995 Stein G Selective expression of fos-related and jun-related genes during osteoblast proliferation and differentiation Exp. Cell Res. 218 255-62
49. McEwan A J 1994 Palliation of bone pain Clinical Nuclear Medicine in Diagnosis and Therapy ed I P C Murray and P J Ell (London: Churchill Livingstone) pp 877-92
50. Mertens W C, Porter A T, Reid R H and Powe J E 1992 Strontium-89 and low dose infusion cisplatin for patients with hormone refractory prostate carcinoma to bone: A preliminary report J. Nucl. Med. 33 1437-43
51. Mundy G R 1992 Cytokines and local factors which affect osteoclast function Int. J. Cell Cloning 10 215-22
52. Oster ZH et al 1985 The development and in vivo behaviour of tin containing radiopharmaceuticals II. Autoradiographic and scintigraphic studies in normal animals and in animal models of bone disease Int. J. Nucl. Med. Biol. 12 175-84
53. Porter A T et al 1993 Results of a randomised phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostatic cancer Int. J. Radiat. Oncol. Biol. Phys. 25 805-13
54. Potsaid M, Irwin R and Castronova F 1976 Phosphorus-32 EHDP clinical study of patients with prostate carcinoma bone metastases J. Nucl. Med. 17 548-9
55. Price P, Hoskin P J, Easton P, Austin D, Palmer S G and Yarnold J R 1986 Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases Radiother. Oncol. 6 247-55
56. Price P, Hoskin P J, Easton D, Austin D, Palmer S and Yamold J R 1988 Low dose single fraction radiotherapy in the treatment of metastatic bone pain: a pilot study Radiother. Oncol. 12 297-300
57. Quilty P M, Kirk D, Bolger J J, Dearnaley D P, Lewington V J, Mason M D, Reed N S, Russell J M and Yardley J 1994 A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostatic carcinoma Radiother. Oncol. 31 33-40
58. Reinhard E H, Moore C V, Bierbaum O S and Moore S 1946 Radioactive phosphorus as a therapeutic agent. A review of the literature and analysis of results of treatment of 155 patients with various blood diseases, lymphomas and other malignant neoplastic diseases J. Lab. Clin. Med. 31 107-215
59. Robinson R G, Spicer J A, Preston D F, Wegst A V and Martin N L 1987 Treatment of metastatic bone pain with strontium-89 Nucl. Med. Biol. 14 219-22
60. Roche E and Prentki M 1994 Calcium regulation of immediate early response genes Cell Calcium 16 331-8
61. Samaratunga R C, Thomas S R, Hinnefeld J D, von Kuster L C, Hyams D M, Moulton J S, Sperling M I and Maxon H R III 1995 A Monte Carlo simulation model for radiation dose to metastatic skeletal tumour from rhenium 186(Sn) HEDP J. Nucl. Med. 36 336-50
62. Silberstein E B and Williams C 1983 Strontium-89 therapy for the pain of osseous metastases J. Nucl. Med. 26 345-8
63. Silberstein E B 1993 The treatment of painful osseous metastases with phosphorus-32 labeled phosphates Semin. Oncol. 3 (suppl 2) 10-2121
64. Singh A, Holmes R A, Farhangi M, Volkert W A, Williams A, Stringham L and Ketring A R 1989 Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer J. Nucl. Med. 30 1814-8
65. Spiers F W, Beddoe A H and King S D 1976 The absorbed dose to bone marrow in the treatment of polycythaemia by P-32 Br. J. Radiol. 49 133-40
66. Spiers F W, Beddoe A H and Whitwell J R 1981 Mean skeletal dose factors for beta particle emitters in human bone. Part II: surface seeking radionuclides Br. J. Radiol. 54 500-4
67. Srivastava S C, Meinken G E, Richards P, Som P, Oster Z H, Atkins H L, Brill A B, Knapp F F and Butler T A 1985 The development and in vivo behaviour of tin containing radiopharmaceuticals I. Chemistry, preparation and biodistribution in small animals Int. J. Nucl. Med. Biol. 12 167-74
68. Storaasli J P, King R L, Krieger H, Abbott W E and Friedell H L 1961 Palliation of osseous metastates from breast carcinoma with radioactive phosporus alone and in combination with adrenalectomy Radiology 76 422-30
69. Thompson B M, Saklatvala J and Chambers T J 1986 Osteoblasts mediate interleukin-I responsiveness of bone resorption by rat osteoclasts J. Exp. Med. 164 104-12
70. Tong E C K 1971 Parathormone and P-32 therapy in prostatic cancer with bone metastases Radiology 98 343-51
71. Turner J H and Claringbold P G 1991 A Phase II study of treatment of painful multifocal skeletal metastases with singleand repeated dose samarium-153 ethylenediaminetetramethylenephosphonate Eur. J. Cancer 27 1084-6
72. Twycross R G and Fairfield S 1982 Pain in far advanced cancer Pain 14 303-10
73. Ventafridda V, Sbanotto A and de Conno F 1990 Pain in prostrate cancer Pall. Med. 4 173-84
74. Weichselbaum R R, Hallahan D, Sukhatme V, Dritschilo A, Sherman M L and Kufe D W 1991 Biological consequences of gene regulation after ionising radiation exposure J. Natl. Cancer Inst. 83 480-4
75. Weichselbaum R R, Hallahan D, Fuks Z and Kufe D 1994 Radiation induction of immediate early genes-effectors of the radiation stress response Int. J. Radiat. Oncol. Biol. Phys. 30 229-34
76. 2+ and the regulation of early response gene expression in HL-60 myeloid leukaemia cells J. Biol. Chem. 268 16 596-601
77. Wheldon T E 1994 Targeting radiation to tumours Int. J. Radiat. Biol. 65 109-16
78. Zonnenberg B A, de Klerk J M H, van Rijk P P, Quirijnen J M S P, van het Schip A D, van Dijk A and ten Kroode N F J 1991 Re-186-HEDP frotreatment of painful bone metastases in patients with metastatic prostate or breast cancer. Preliminary results J. Nucl. Med. 32 1082